← Back to Search

Platelet Rich Plasma

Platelet Rich Plasma Injection Group for Plantar Fasciitis

N/A
Waitlist Available
Led By Amanda L Allen, MD
Research Sponsored by William Beaumont Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6, 12, 24 weeks
Awards & highlights

Study Summary

A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy with Platelet Rich Plasma versus Extracorporeal Shock Wave Therapy in a High Demand Cohort with Resistant Plantar Fasciitis

Eligible Conditions
  • Plantar Fasciitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6, 12, 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, 12, 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual analog scale (VAS)
Secondary outcome measures
Functional Ankle Ability Measure (FAAM)
Functional Ankle Ability Measure extended sports scale
repeat treatment threshold
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Platelet Rich Plasma Injection GroupExperimental Treatment1 Intervention
shockwave therapy within standard of care using Ossatron system with intervention injection of platelet rich plasma (PRP) using Arthex system, into the plantar fascia at the calcaneal origin
Group II: Placebo injection groupPlacebo Group1 Intervention
shockwave therapy with placebo normal saline injection
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
platelet rich plasma
2014
Completed Phase 4
~650

Find a Location

Who is running the clinical trial?

William Beaumont Army Medical CenterLead Sponsor
16 Previous Clinical Trials
2,316 Total Patients Enrolled
Amanda L Allen, MDPrincipal InvestigatorWBAMC
Lola NortonStudy DirectorWBAMC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Foot & Ankle InternationalJournal
Evidence of Validity for the Foot and Ankle Ability Measure (FAAM)
Martin, RobRoy L., James J. Irrgang, Ray G. Burdett, Stephen F. Conti, and Jessie M. Van Swearingen. 2005. “Evidence of Validity for the Foot and Ankle Ability Measure (FAAM)”. Foot & Ankle International. SAGE Publications. doi:10.1177/107110070502601113.
clinicaltrials.govStudy
RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort
2016. "RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02668510.
All > Plantar Fasciitis
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top